“…In this context, biobanks are important platforms that store vast amounts of samples, participants' biodata, and big data generated by high-throughput "OMICs" platforms [3,[40][41][42], which contribute significantly to the implementation of precision medicine to improve the quality of healthcare services provided worldwide. Although many studies have investigated the knowledge and attitudes of the public [24,[43][44][45][46][47][48], patients [43,[49][50][51], and universities students' [16,52] towards biobanks, there are few studies that focus on healthcare stakeholders, especially in developing countries such as Saudi Arabia. With this in mind, it is important to conduct an initial assessment of the general level of knowledge and attitudes toward biobanks in this geographic area before determining appropriate programs for education, awareness, and national adoption of biobanks.…”